Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go:
TBC
investment:
Withheld
Erpingham House is the UK’s largest vegan restaurant whose aim is to make plant-based dining into the mainstream and provide delicious, healthy food and drinks to people. The company has earned nationwide recognition and, it has been listed in The Times top 20 vegetarian restaurants. It has also been featured in The Guardian and on channel 4’s “what Britain bought.” EH has served over 12,000 customers in its first year and, it has risen to over 20,000 followers on Instagram. The funds will be used to expand the brand & open a second site in Brighton.
days to go:
Expired
investment:
£192,280
Co-founders TommyD and Paul Pullinger have created a signature whisky blend to define the music loving generation of today. 8O8 has all the heritage, depth and soul of a classic scotch, but has been shaped for the 21st century. It has been blended to be enjoyed on its own, but is also versatile to be mixed into a cocktail.
days to go:
Expired
investment:
£954,496
SaaS allowing caterers globally to ensure accuracy and efficiency with enhanced operating margins.
days to go:
Expired
investment:
£154,540
Miso Tasty make Japanese inspired snacks and meals and currently have a range of Miso soups, Miso pastes, meal kits and even a cookbook. Their products are stocked in over 1,000 stores nationwide such as Waitrose, Sainsburys, Ocado, Wholefoods and Selfridges.
days to go:
Expired
investment:
£421,400
An innovative and flourishing brewery, with music as its main source of inspiration. Signature Brew has won multiple awards for their beers, including the SIBA for Brewery Business of the Year 2018. The company is passionate abut serving brews alongside bands; their collaborations include Foo Fighters, Frank Turner, Mastodon and alt-J.
Signature Brew's core beers are enjoyed nationwide, such as Studio Pilsner and Roadie. Their products are sold in bars, pubs and supermarkets, as well as at venues and festivals. Over the past 3 years, the company has seen YoY growth of 78%, with revenues of £1.13m in the last 12 months.
Signature Brew is currently producing over 1m pints per year and is now seeking investment to increase capacity. The company intends to move its services to a nearly site in East London and develop a new brew house. This will result in capacity increasing by three-fold. In addition, Signature Brew intends to open two more taprooms to host events and showcase their beers.
days to go:
Expired
investment:
£567,030
Mercato Metropolitano represents a revival of traditional street food market with an Italian soul within the UK and beyond. The current London location has already attracted an estimated 590,000 people* through its doors since November 2016 to July 2017. Yet, MM is more than just a food market. The MM concept is proving popular because it offers visitors a trusted destination for friends to enjoy a fantastic range of highly-curated Mediterranean street food, artisan groceries to take home and inclusive entertainment, featuring an immersive cinema offering as well as local live music. What stands out for many visitors, is the relaxed atmosphere focused on the local community.
days to go:
Expired
investment:
£577,587
